Johnson & Johnson 2022 Investor Fact Sheet

Johnson & Johnson's 2022 investor fact sheet outlines the company's life-enhancing innovation and operational excellence across its three business segments: Pharmaceutical, MedTech, and Consumer Health. The document highlights key financial metrics, including net earnings of $48.6B, 6.1% operational sales growth, and over 60 consecutive years of dividend increases. J&J emphasizes its diversified healthcare portfolio, robust R&D pipeline, and strategic capital allocation priorities focused on delivering long-term shareholder value.